A pH-responsive T1-T2 dual-modal MRI contrast agent for cancer imaging

By A Mystery Man Writer

Last updated 03 Jun 2024

A pH-responsive T1-T2 dual-modal MRI contrast agent for cancer imaging

T1–T2 Dual-modal MRI contrast agents based on superparamagnetic

Advances in the application of manganese dioxide and its composites for theranostics - Inorganic Chemistry Frontiers (RSC Publishing) DOI:10.1039/D3QI00978E

T1-T2 Dual-Modal Magnetic Resonance Imaging: From Molecular Basis

Magnetic Nanoparticles as MRI Contrast Agents

Tracking the immune response by MRI using biodegradable and

Recent development of contrast agents for magnetic resonance and

Poly(ethylene) oxide/erbium oxide as T2 and T1-T2 dual-mode MRI diagnostic nanofibres - ScienceDirect

A pH-responsive T1-T2 dual-modal MRI contrast agent for cancer

New nanoparticle-based contrast agent that is pH dependent

Ultrasmall T1–T2 Magnetic Resonance Multimodal Imaging Nanoprobes for the Detection of β-amyloid Aggregates in Alzheimer's Disease Mice

A)Temperature dependent 17 O NMR transverse relaxation rates of MnL Me

Magnetic Particle Imaging for Highly Sensitive, Quantitative, and Safe in Vivo Gut Bleed Detection in a Murine Model

PDF) A pH-responsive T1-T2 dual-modal MRI contrast agent for cancer imaging

Large T1 contrast enhancement using superparamagnetic nanoparticles in ultra-low field MRI

Synthesis of Ultrasmall Fe3O4 Nanoparticles as T1–T2 Dual-Modal Magnetic Resonance Imaging Contrast Agents in Rabbit Hepatic Tumors

Recommended for you